Clinical trial

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared…

NCT00004031 · SWOG Cancer Research Network, Other · Completed

Key facts

NCT number NCT00004031
Title SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Official title SWOG-9704 A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas (With Possible Late Autologous Stem Cell Transplant) for Patients With Diffuse Aggressive…
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH Cancer and Leukemia Group B Eastern Cooperative Oncology Group NCIC Clinical Trials Group
Status Completed
Phase Phase 3
Study type Interventional
Conditions Lymphoma
Intervention type Biological, Drug, Procedure, Radiation
Interventions rituximab, CHOP regimen, carmustine, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, vincristine sulfate, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation and 1 more
Enrollment 397
Start date Jul 1, 1997
Primary completion Jun 1, 2008
Completion Oct 31, 2013
First posted Jan 27, 2003
Last update posted Feb 2, 2021
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies